ARTICLE
9 April 2025

Legal Tussle: Novartis' Entresto Patent Victory

E
ENS

Contributor

ENS is an independent law firm with over 200 years of experience. The firm has over 600 practitioners in 14 offices on the continent, in Ghana, Mauritius, Namibia, Rwanda, South Africa, Tanzania and Uganda.
Novartis recently secured a crucial win in its patent battle over the heart failure drug Entresto, temporarily blocking generic competition from MSN Pharmaceuticals. The U.S. Court of Appeals for the Federal Circuit...
South Africa Intellectual Property

Novartis recently secured a crucial win in its patent battle over the heart failure drug Entresto, temporarily blocking generic competition from MSN Pharmaceuticals. The U.S. Court of Appeals for the Federal Circuit reversed a lower court decision, upholding the validity of a key patent. What's the lesson here? Understanding and defending your patent rights is paramount.

Why does this matter?

The legal back-and-forth illustrates the complex landscape of pharmaceutical patent law. Novartis' Entresto, a blockbuster drug generating over $6 billion in revenue in 2023, faced challenges regarding the written description of its active ingredients, valsartan and sacubitril. The court's ruling hinged on whether the patent adequately described the claimed combination, not later-discovered "complex" formations.

The Crucial defence

Novartis' successful appeal ensures market exclusivity until at least July 2025, when the paediatric exclusivity period expires. This victory safeguards a significant revenue stream and underscores the importance of robust patent protection. Had Novartis not vigorously defended its patent, it risked losing market share to generic competitors.

What does this teach us?

The Novartis case highlights the necessity of:

  • Precise patent drafting: Ensuring that patents clearly describe the claimed inventions is crucial to withstand legal challenges.
  • Vigilant enforcement: Proactively defending patents against infringement is essential for maintaining market exclusivity.
  • Understanding patent nuances: Navigating the complexities of patent law, including written descriptions and obviousness challenges, is vital for success.

In the pharmaceutical industry, where innovation drives progress, protecting intellectual property is non-negotiable. The Entresto saga serves as a powerful reminder that proactive and strategic patent defence can make the difference between market dominance and losing out to competitors.

Secure your patents and protect your innovations for the long term!

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More